CBR1-IN-6
CBR1-IN-6 (compound 1a) is a CBR1 inhibitor with chemosensitizing and cardioprotective activities[1].
Product Specifications
UNSPSC
12352005
Target
Apoptosis
Type
Reference compound
Related Pathways
Apoptosis
Applications
Cancer-programmed cell death
Field of Research
Cancer
Assay Protocol
https://www.medchemexpress.com/cbr1-in-6.html
Solubility
10 mM in DMSO
Smiles
ClC1=CC=C(/C=C/C(N2CCC(O)CC2)=O)C=C1
Molecular Formula
C14H16ClNO2
Molecular Weight
265.74
References & Citations
[1]Paulina Koczurkiewicz-Adamczyk, et al. Cinnamamide derivatives with 4-hydroxypiperidine moiety enhance effect of doxorubicin to cancer cells and protect cardiomyocytes against drug-induced toxicity through CBR1 inhibition mechanism. Life Sci. 2022 Sep 15:305:120777.
Shipping Conditions
Room temperature
Scientific Category
Reference compound1
Clinical Information
No Development Reported
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog